AZD6234
A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234
AstraZeneca · Phase 1 · Not yet recruiting · Enrollment 60
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Regimen A | n/r | n/r | n/r | n/r | n/r |
| Regimen B | n/r | n/r | n/r | n/r | n/r |
| Regimen C | n/r | n/r | n/r | n/r | n/r |
| Regimen D | n/r | n/r | n/r | n/r | n/r |
| Regimen E | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.